The UMD TP53 database and website: update and revisions - PubMed (original) (raw)

The UMD TP53 database and website: update and revisions

Dalil Hamroun et al. Hum Mutat. 2006 Jan.

Abstract

Mutation of the p53 gene is the most frequent genetic alteration found in human cancer, but it is also the most frequently reported with more than 22,000 mutations published in 2,000 papers. In 1991, we developed a database and software to handle and analyze all this information. The database has been widely used for clinical analysis and molecular epidemiology. We have expanded the scope of the database by integrating structural, phylogenetic and biological information on wild-type (wt) and mutant TP53. Integration of the TP53 mutant activity database provides unique information that will be useful to both clinicians and scientists. All of this information is available from a new website (www.umd.be:2072/) that will generate a detailed informative page for every TP53 mutant in the database. New tools to check TP53 mutations and minimize errors found in the literature are also available.

2005 Wiley-Liss, Inc.

PubMed Disclaimer

Similar articles

• The UMD-p53 database: new mutations and analysis tools.
  Béroud C, Soussi T. Béroud C, et al. Hum Mutat. 2003 Mar;21(3):176-81. doi: 10.1002/humu.10187. Hum Mutat. 2003. PMID: 12619103 Review.
• The IARC TP53 database: new online mutation analysis and recommendations to users.
  Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. Olivier M, et al. Hum Mutat. 2002 Jun;19(6):607-14. doi: 10.1002/humu.10081. Hum Mutat. 2002. PMID: 12007217
• MUT-TP53 2.0: a novel versatile matrix for statistical analysis of TP53 mutations in human cancer.
  Soussi T, Hamroun D, Hjortsberg L, Rubio-Nevado JM, Fournier JL, Béroud C. Soussi T, et al. Hum Mutat. 2010 Sep;31(9):1020-5. doi: 10.1002/humu.21313. Hum Mutat. 2010. PMID: 20572016
• Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
  Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M. Petitjean A, et al. Hum Mutat. 2007 Jun;28(6):622-9. doi: 10.1002/humu.20495. Hum Mutat. 2007. PMID: 17311302
• The UMD-LDLR database: additions to the software and 490 new entries to the database.
  Villéger L, Abifadel M, Allard D, Rabès JP, Thiart R, Kotze MJ, Béroud C, Junien C, Boileau C, Varret M. Villéger L, et al. Hum Mutat. 2002 Aug;20(2):81-7. doi: 10.1002/humu.10102. Hum Mutat. 2002. PMID: 12124988 Review.

Cited by

• Role of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression.
  Uehara I, Tanaka N. Uehara I, et al. Cancers (Basel). 2018 Jun 27;10(7):219. doi: 10.3390/cancers10070219. Cancers (Basel). 2018. PMID: 29954119 Free PMC article. Review.
• DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers.
  Wang D, Qian X, Rajaram M, Durkin ME, Lowy DR. Wang D, et al. Oncotarget. 2016 Jul 19;7(29):45144-45157. doi: 10.18632/oncotarget.9266. Oncotarget. 2016. PMID: 27174913 Free PMC article.
• Overexpression of RAD51 occurs in aggressive prostatic cancer.
  Mitra A, Jameson C, Barbachano Y, Sanchez L, Kote-Jarai Z, Peock S, Sodha N, Bancroft E, Fletcher A, Cooper C, Easton D; IMPACT Steering Committee and IMPACT and EMBRACE Collaborators; Eeles R, Foster CS. Mitra A, et al. Histopathology. 2009 Dec;55(6):696-704. doi: 10.1111/j.1365-2559.2009.03448.x. Histopathology. 2009. PMID: 20002770 Free PMC article.
• Association of Single-Nucleotide Polymorphisms in Monoubiquitinated FANCD2-DNA Damage Repair Pathway Genes With Breast Cancer in the Chinese Population.
  Chen FY, Wang H, Li H, Hu XL, Dai X, Wang SM, Yan GJ, Jiang PL, Hu YP, Huang J, Tang LL. Chen FY, et al. Technol Cancer Res Treat. 2018 Jan 1;17:1533033818819841. doi: 10.1177/1533033818819841. Technol Cancer Res Treat. 2018. PMID: 30799775 Free PMC article.
• Identifying the Antiproliferative Effect of Astragalus Polysaccharides on Breast Cancer: Coupling Network Pharmacology With Targetable Screening From the Cancer Genome Atlas.
  Liu C, Li H, Wang K, Zhuang J, Chu F, Gao C, Liu L, Feng F, Zhou C, Zhang W, Sun C. Liu C, et al. Front Oncol. 2019 May 17;9:368. doi: 10.3389/fonc.2019.00368. eCollection 2019. Front Oncol. 2019. PMID: 31157164 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal